The targeted deep-sequencing assay Deeplex Myc-TB can be used directly on sputum specimens with relatively high mycobacterial load for the prediction of resistance to 11 anti-tuberculous drugs/drug classes when investigating 18 of the 50 candidate resistance genes. The gene discussed is MYC; the disease is tuberculosis.